Hunan Tigermed Xiangya Drug R&D will boost the firm’s Phase I trial service capabilities.

Tigermed Consulting has established a subsidiary, Hunan Tigermed Xiangya Drug R&D, with Central South University (CSU). The establishment of Tigermed Xiangya advances Tigermed’s service ability in preclinical studies and pharmaceutical analysis, according to the company. The collaboration with CSU allows Tigermed to provide more comprehensive outsourcing clinical services for multinational pharmaceutical corporations and local research institutions in the research and development of innovative drugs, it reports.

“Tigermed Xiangya is a significant move for us to complete our clinical service chain and this union of two titans will tremendously boost Tigermed’s serviceability in Phase I clinical trials,” comments Cao Xiaochun, vp of Tigermed.

Previous articleVical Pockets $1M Milestone from Merck & Co.
Next articleFerring Pharmaceuticals to Distribute Auxilium Pharmaceuticals’ Testim in Europe